Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Dopamine D3 receptor-selective CNS agents disclosed by BASF

Sep. 17, 1997

Potential antipsychotics under development at Taisho/Nihon Nohyaku

Sep. 16, 1997

Mitsubishi describes synthesis and activity of MKC-242

Sep. 15, 1997

Novel neuroprotective agent developed at Takeda

Sep. 15, 1997

Cardiovascular effects of SB-209509 and sumatriptan compared in dogs

Sep. 15, 1997

Amphetamines may provide long-term benefit in patients with ADHD

Sep. 15, 1997

Kyowa Hakko antiparkinsonian enters phase II trials

Sep. 15, 1997

Preclinical studies show broad antiseizure properties of ganaxolone

Sep. 15, 1997

Capases: a new target for neurodegenerative disease therapy

Sep. 12, 1997

Essential tremor gene located by Icelandic genomics company

Sep. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...